CSI Market
Sign In | Register

Zimmer Biomet Holdings Inc (ZBH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ZBH Annual Cash Flow →
The quarterly cash flow data below helps track how Zimmer Biomet Holdings Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income437.90
Depreciation & amortization540.80
Amortization of Other Assets325.50
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories51.40
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation48.80
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-9.80
Net Curtailment Settlement Gains-
Tax Benefit From Stock Options Exercised-
Business Combination Consideration Compensation Expense-
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest238.30
Income taxes0.00
Gain (Loss) on Investments0.00
Increase (Decrease) in Receivables24.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-91.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-26.10
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-494.30
Discontinued operations0.00
Net Cash flow from Operating Activities807.20
Investing Activities
Capital Expenditures-191.70
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt0.00
Payments to Acquire Available-for-sale Securities, Debt0.00
Payments for (Proceeds from) Hedge, Investing Activities10.80
Additions To Instruments-77.20
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Business Two, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-6.30
Other Net-162.60
Discontinued operations0.00
Net Cash Flow from Investing Activities-349.80
Financing Activities
Short-term debt Net30.00
Other borrowing transactions-1.30
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-488.40
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-17.90
Other net-69.30
Cash Flows Between Transferee And Transferor Receipts On Interests Th at Continue To Be Held Other-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-93.40
Net Cash Flow from Financing Activities-640.30
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow615.50
Total Cash Flow-181.90
4 historic quarters locked

Sign in to unlock the full Zimmer Biomet Holdings Inc cash flow history.

Sign In Create Free Account

About Zimmer Biomet Holdings Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 5, 2026
  • Source: zbh-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-335044

Figures are derived from filed reports and may be restated. Historical data is subject to revision.